Sex: M
Vaccine: COVID19, FLU3, FLUX, PPV, VARZOS
Symptoms: Gait disturbance, Nausea, Pain in extremity, Pyrexia, Scan
Clinical narrative: difficulty walking, the patient needed about 3 people to help him walk; unstable; energy and strength have not been fully regained; chills; nausea; sore arm; fever(101.7F); Initial information received on 14-Jul-2022 regarding an unsolicited valid serious case received from a consumer/non-hcp.  This case involves Adult male (unknown age) patient who experienced chills, fever (101.7f), nausea, unstable, difficulty walking, the patient needed about 3 people to help him  wal, energy and strength have not been fully regained and sore arm while receiving vaccines covid-19 vaccine, shingrix, pneumovax, influenza vaccine and influenza USP trival A-B subvirion no preservative vaccine [fluzone].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE lot number not reported via intramuscular route in the left deltoid. On 28-Oct-2021, the patient received a  dose of suspect shingrix not produced by Sanofi Pasteur lot number not reported via intramuscular route in unknown administration site.On an unknown date, the patient received a  dose of suspect influenza usp trival a-b subvirion no preservative vaccine (strength, dose, formulation, lot number: not reported) via intramuscular route in the left deltoid ,Pneumovax not produced by Sanofi Pasteur (strength, dose, formulation, lot number: not reported) in unknown administration site, covid-19 vaccine not produced by Sanofi Pasteur (strength, dose, formulation, lot number: not reported), influenza vaccine produced by unknown manufacturer (strength, dose, formulation, lot number: not reported) in unknown administration site all for prophylactic vaccination.  On 29-OCT-2021 the patient developed a non-serious chills, fever (101.7f) (pyrexia), nausea, unstable (feeling abnormal), difficulty walking, energy and strength have not been fully regained (asthenia), sore arm (pain in extremity) (unknown latency) and the patient needed about 3 people to help him walk (gait disturbance), This event was leading to disability. The patient was hospitalized around 4:00 pm on the same day for all the events. The patient was discharged from Emergency room  around 09:30 pm on 29-Oct-2021 (hospitalization 1 day) following the administration of influenza usp trival a-b subvirion no preservative vaccine, influenza vaccine, pneumovax, shingrix and covid-19 vaccine.  It was reported Guillain-Barre syndrome (GBS) has not been diagnosed, but the reporter thinks that symptoms were like GBS. The reporter also mentioned that the patient had similar reaction/symptoms when he received FLUZONE and PNEUMOVAX about a year ago. The reporter also mentioned that the patient received COVID shots (1st and 2nd dose), but no major reaction other than sore arm. And 2 weeks prior to SHINGRIX vaccine, he received flu shot, but no adverse reactions.  Relevant laboratory test results included: Blood test - On an unknown date: [normal] Body temperature - On 29-Oct-2021: 101.7 F Scan - On an unknown date: [No signs of stroke]   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (chills, pyrexia nausea, feeling unstable, difficulty walking, asthenia, gait disturbance, pain in extremity)  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event chills, pyrexia nausea, feeling unstable, difficulty walking,  gait disturbance, was Not Recovered / Not Resolved for the event asthenia d and was Unknown for the event pain in extremity.; Sender's Comments: Sanofi Company Comment dated 20-Jul-2022: This case involves Adult male (unknown age) patient who experienced chills, fever (101.7f), nausea, unstable, difficulty walking, the patient needed about 3 people to help him  walk, energy and strength have not been fully regained and sore arm while receiving vaccines covid-19 vaccine, shingrix, pneumovax, influenza vaccine and influenza USP trival A-B subvirion no preservative vaccine [fluzone].Further information regarding medical history, concurrent condition during vaccination, previous vaccination, concomitant medication and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the individual suspect vaccine cannot be assessed.